BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
38 results:

  • 1. prostate cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges.
    Manfredi C; Ditonno F; Franco A; Bologna E; Licari LC; Arcaniolo D; Tubaro A; De Nunzio C; Antonelli A; De Sio M; Cherullo EE; Autorino R
    Curr Oncol Rep; 2023 Dec; 25(12):1431-1443. PubMed ID: 37910274
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
    Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
    Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. "Residential greenness and site-specific cancer: A registry based cohort of 144,427 participants with a 21-years of follow-up, tel-Aviv district, Israel".
    Kayyal-Tarabeia I; Michael Y; Lensky IM; Blank M; Agay-Shay K
    Environ Res; 2022 Sep; 212(Pt C):113460. PubMed ID: 35561833
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.
    Chung JW; Kim HT; Ha YS; Lee EH; Chun SY; Lee CH; Byeon KH; Choi SH; Lee JN; Kim BS; Kim TH; Yoo ES; Yoon GS; Baek MC; Kwon TG
    PLoS One; 2021; 16(4):e0250254. PubMed ID: 33901217
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Significance of Primary Biopsy Gleason 5 in Patients with Grade Group 5 prostate cancer.
    Tilki D; Würnschimmel C; Preisser F; Graefen M; Huland H; Mandel P; Tennstedt P
    Eur Urol Focus; 2020 Mar; 6(2):255-258. PubMed ID: 32033909
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Fararjeh AS; Liu YN
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181727
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative structure analysis of the ETSi domain of ERG3 and its complex with the E74 promoter DNA sequence.
    Sharma R; Gangwar SP; Saxena AK
    Acta Crystallogr F Struct Biol Commun; 2018 Oct; 74(Pt 10):656-663. PubMed ID: 30279318
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluating the biological properties of synthetic 4-nitrophenyl functionalized benzofuran derivatives with telomeric DNA binding and antiproliferative activities.
    Carella A; Roviello V; Iannitti R; Palumbo R; La Manna S; Marasco D; Trifuoggi M; Diana R; Roviello GN
    Int J Biol Macromol; 2019 Jan; 121():77-88. PubMed ID: 30261256
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Monolayer grafting of aminosilane on magnetic nanoparticles: An efficient approach for targeted drug delivery system.
    Dhavale RP; Waifalkar PP; Sharma A; Dhavale RP; Sahoo SC; Kollu P; Chougale AD; Zahn DRT; Salvan G; Patil PS; Patil PB
    J Colloid Interface Sci; 2018 Nov; 529():415-425. PubMed ID: 29940324
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Disruption of etv6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer.
    Tsai YC; Zeng T; Abou-Kheir W; Yeh HL; Yin JJ; Lee YC; Chen WY; Liu YN
    Mol Cancer; 2018 Feb; 17(1):42. PubMed ID: 29455655
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhibition of Androgen Receptor Nuclear Localization and Castration-Resistant prostate Tumor Growth by Pyrroloimidazole-based Small Molecules.
    Masoodi KZ; Xu Y; Dar JA; Eisermann K; Pascal LE; Parrinello E; Ai J; Johnston PA; Nelson JB; Wipf P; Wang Z
    Mol Cancer Ther; 2017 Oct; 16(10):2120-2129. PubMed ID: 28655783
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
    Coyle C; Cafferty FH; Rowley S; MacKenzie M; Berkman L; Gupta S; Pramesh CS; Gilbert D; Kynaston H; Cameron D; Wilson RH; Ring A; Langley RE;
    Contemp Clin Trials; 2016 Nov; 51():56-64. PubMed ID: 27777129
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor etv6.
    Tsai YC; Chen WY; Siu MK; Tsai HY; Yin JJ; Huang J; Liu YN
    Cancer Lett; 2017 Jan; 384():1-8. PubMed ID: 27746161
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Does Choline PET/CT Change the Management of prostate cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells.
    Kaur M; Bhatia RK; Pissurlenkar RR; Coutinho EC; Jain UK; Katare OP; Chandra R; Madan J
    Carbohydr Polym; 2014 Jan; 101():614-22. PubMed ID: 24299818
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.
    Ames HM; Wang AA; Coughran A; Evaul K; Huang S; Graves CW; Soyombo AA; Ross TS
    Mol Cell Biol; 2013 Sep; 33(18):3580-93. PubMed ID: 23836884
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overexpression of matrix metalloproteinase 11 in Thai prostatic adenocarcinoma is associated with poor survival.
    Nonsrijun N; Mitchai J; Brown K; Leksomboon R; Tuamsuk P
    Asian Pac J Cancer Prev; 2013; 14(5):3331-5. PubMed ID: 23803125
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Discovery of a selective irreversible BMX inhibitor for prostate cancer.
    Liu F; Zhang X; Weisberg E; Chen S; Hur W; Wu H; Zhao Z; Wang W; Mao M; Cai C; Simon NI; Sanda T; Wang J; Look AT; Griffin JD; Balk SP; Liu Q; Gray NS
    ACS Chem Biol; 2013 Jul; 8(7):1423-8. PubMed ID: 23594111
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.